3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Use of Lipid-modifying Therapy and LDL-C Goal Attainment in a High-Cardiovascular-Risk Population in the Netherlands.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This study investigates lipid-modifying therapy (LMT) and LDL-C goal attainment in a real-world, high-cardiovascular-risk population in the Netherlands.

          Related collections

          Author and article information

          Journal
          Clin Ther
          Clinical therapeutics
          Elsevier BV
          1879-114X
          0149-2918
          Apr 2017
          : 39
          : 4
          Affiliations
          [1 ] PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands. Electronic address: Josine.kuiper@pharmo.nl.
          [2 ] Regeneron, Tarrytown, New York.
          [3 ] PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands.
          [4 ] Sanofi, Bridgewater, New Jersey.
          [5 ] Sanofi, Gouda, the Netherlands.
          Article
          S0149-2918(17)30175-3
          10.1016/j.clinthera.2017.03.001
          28347514

          prevention, cardiovascular disease, statin, LDL-C

          Comments

          Comment on this article